{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:21:10Z","timestamp":1780680070944,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ando.2019.09.003","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T19:17:30Z","timestamp":1571426250000},"page":"324-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Metallothionein protein and minichromosome maintenance protein-2 expression in adrenocortical tumors"],"prefix":"10.1016","volume":"80","author":[{"given":"Leonard","family":"Saiegh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Sheikh-Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Shechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Reut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusef","family":"Darawsha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagit","family":"Zolotov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hila","family":"Shefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Bejar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Bejar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2019.09.003_bib0205","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00268-005-0329-x","article-title":"Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?","volume":"30","author":"Kebebew","year":"2006","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2019.09.003_bib0210","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2019.09.003_bib0215","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors","volume":"8","author":"Weiss","year":"1984","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ando.2019.09.003_bib0220","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/00000478-200212000-00009","article-title":"Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors","volume":"26","author":"Aubert","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ando.2019.09.003_bib0225","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2019.09.003_bib0230","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/annonc\/mdv329","article-title":"Prognostic factors in stage III\u2013IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study","volume":"26","author":"Lib\u00e9","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ando.2019.09.003_bib0235","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.humpath.2014.11.015","article-title":"Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas","volume":"46","author":"Pennanen","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ando.2019.09.003_bib0240","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1021\/cr020620d","article-title":"zinc, cadmium, mercury, and copper thiolates and selenolates mimicking protein active site features--structural aspects and biological implications","volume":"104","author":"Henkel","year":"2004","journal-title":"Chem Rev"},{"key":"10.1016\/j.ando.2019.09.003_bib0245","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2559.1997.2140848.x","article-title":"Significance of metallothionein overexpression in human tumours","volume":"31","author":"Jasani","year":"1997","journal-title":"Histopathology"},{"key":"10.1016\/j.ando.2019.09.003_bib0250","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1073\/pnas.92.2.579","article-title":"Cell cycle regulation of metallothionein in human colonic cancer cells","volume":"92","author":"Nagel","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ando.2019.09.003_bib0255","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00018-002-8454-2","article-title":"Metallothionein: the multipurpose protein","volume":"59","author":"Coyle","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ando.2019.09.003_bib0260","doi-asserted-by":"crossref","first-page":"8428","DOI":"10.1073\/pnas.95.15.8428","article-title":"The elusive function of metallothioneins","volume":"95","author":"Palmiter","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ando.2019.09.003_bib0265","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s12022-013-9280-9","article-title":"Metallothionein-3 (MT-3) in the human adrenal cortex and its disorders","volume":"25","author":"Felizola","year":"2014","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.ando.2019.09.003_bib0270","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/sj.bjc.6690753","article-title":"Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus","volume":"81","author":"Hishikawa","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ando.2019.09.003_bib0275","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/sj.bjc.6603028","article-title":"Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients","volume":"94","author":"Weinlich","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ando.2019.09.003_bib0280","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/genetics\/106.3.365","article-title":"Mutants of S. cerevisiae defective in the maintenance of minichromosomes","volume":"106","author":"Maine","year":"1984","journal-title":"Genetics"},{"key":"10.1016\/j.ando.2019.09.003_bib0285","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/nar\/gkg395","article-title":"A new member of the MCM protein family encoded by the humanMCM8 gene, located contrapodal to GCD10 at chromosome band 20p12.3-13","volume":"31","author":"Johnson","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ando.2019.09.003_bib0290","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/02688690120114174","article-title":"Early recurrence of benign meningioma correlates with expression of mini-chromosome maintenance-2 protein","volume":"16","author":"Hunt","year":"2002","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.ando.2019.09.003_bib0295","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2407-1-6","article-title":"MCM2--a promising marker for premalignant lesions of the lung: a cohort study","volume":"1","author":"Tan","year":"2001","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ando.2019.09.003_bib0300","first-page":"1075","article-title":"Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility","volume":"8","author":"Rodins","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ando.2019.09.003_bib0305","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10120-008-0451-1","article-title":"Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance","volume":"11","author":"Tokuyasu","year":"2008","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ando.2019.09.003_bib0310","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s10620-008-0305-z","article-title":"Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity","volume":"54","author":"Giaginis","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ando.2019.09.003_bib0315","first-page":"2959","article-title":"Immunohistochemical evaluation of metallothionein. Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex","volume":"28","author":"Szajerka","year":"2008","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ando.2019.09.003_bib0320","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2559.2007.02747.x","article-title":"The prognostic value of two different histopathological scoring systems for adrenocortical carcinomas","volume":"51","author":"van\u2019t Sant","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.ando.2019.09.003_bib0325","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12672-011-0088-0","article-title":"The Weiss score and beyond--histopathology for adrenocortical carcinoma","volume":"2","author":"Papotti","year":"2011","journal-title":"Horm Cancer"},{"key":"10.1016\/j.ando.2019.09.003_bib0330","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2014-3182","article-title":"Major prognostic role of Ki67 in localized adrenocortical carcinoma aftercomplete resection","volume":"100","author":"Beuschlein","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2019.09.003_bib0335","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2006-0706","article-title":"Prognostic parameters of metastatic adrenocortical carcinoma","volume":"92","author":"Assi\u00e9","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2019.09.003_bib0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2016.09.035","article-title":"Validation of the prognostic role of the \u201cHelsinki Score\u201d in 225 cases of adrenocortical carcinoma","volume":"62","author":"Duregon","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ando.2019.09.003_bib0345","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12022-018-9525-8","article-title":"Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms","volume":"29","author":"Mete","year":"2018","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.ando.2019.09.003_bib0350","first-page":"923","article-title":"DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer","volume":"102","author":"Jouinot","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2019.09.003_bib0355","first-page":"335","article-title":"Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer","volume":"27","author":"Pastuszewski","year":"2007","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ando.2019.09.003_bib0360","doi-asserted-by":"crossref","first-page":"e22009","DOI":"10.1371\/journal.pone.0022009","article-title":"Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas","volume":"6","author":"Peng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ando.2019.09.003_bib0365","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrc1548","article-title":"Control of DNA replication and its potential clinical exploitation","volume":"5","author":"Gonzalez","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ando.2019.09.003_bib0370","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1158\/1078-0432.CCR-04-1776","article-title":"Mcm2 Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma","volume":"11","author":"Dudderidge","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ando.2019.09.003_bib0375","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1600-0714.2007.00631.x","article-title":"Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours","volume":"37","author":"Vargas","year":"2008","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.ando.2019.09.003_bib0380","first-page":"253","article-title":"Minichromosome maintenance-2 (MCM2) expression differentiates oral squamous cell carcinoma from pre-cancerous lesions","volume":"37","author":"Razavi","year":"2015","journal-title":"Malays J Pathol"},{"key":"10.1016\/j.ando.2019.09.003_bib0385","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1186\/1471-2407-14-526","article-title":"Minichromosome Maintenance (MCM) Family as potential diagnostic and prognostic tumor markers for human gliomas","volume":"14","author":"Hua","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ando.2019.09.003_bib0390","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2559.2009.03423.x","article-title":"Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification","volume":"55","author":"Volante","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.ando.2019.09.003_bib0395","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1067\/msy.2000.110237","article-title":"Limitations of size as a criterion in the evaluation of adrenal tumors","volume":"128","author":"Barnett","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2019.09.003_bib0400","doi-asserted-by":"crossref","first-page":"50017","DOI":"10.1039\/C7RA10057D","article-title":"Sinomenine inhibits ovarian cancer cell growth and metastasis by mediating the Wnt\/b-catenin pathway via targeting MCM2","volume":"7","author":"Huimin Li","year":"2017","journal-title":"RSC Adv"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426619302148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426619302148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:51:45Z","timestamp":1757717505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426619302148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":40,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0003426619302148"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2019.09.003","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metallothionein protein and minichromosome maintenance protein-2 expression in adrenocortical tumors","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2019.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}